Special Survey for Type 1 or Type 2 Diabetic Patients
NCT01487408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1463
Last updated 2016-03-04
Summary
This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.
Conditions
- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
insulin aspart
Adminstered subcutaneously (s.c., under the skin). Prescribed by physician as a results of normal clinical practice
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- Japan
Study Locations
More Related Trials
-
Special Survey for Paediatric Subjects
NCT01487382 ·Status: COMPLETED
-
Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes
NCT01536600 ·Status: COMPLETED
-
Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
NCT00494988 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus
NCT01542060 ·Status: COMPLETED
-
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
NCT02408120 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®
NCT00709683 ·Status: COMPLETED
-
Insulin Analogues and Severe Hypoglycaemia
NCT00346996 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
NCT01536028 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes
NCT01135927 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
NCT00274274 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
NCT01597713 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)
NCT01278485 ·Status: COMPLETED
-
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
NCT00537303 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study in Japanese Type 2 Diabetes Patients
NCT01055808 ·Status: COMPLETED
-
Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
NCT00869908 ·Status: COMPLETED
-
Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes
NCT01868568 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
NCT01650129 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
NCT01704378 ·Status: COMPLETED ·Phase: PHASE4
-
Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes
NCT01536652 ·Status: COMPLETED
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects
NCT02479022 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
NCT00267683 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
NCT00715780 ·Status: COMPLETED
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects
NCT01809184 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers
NCT01538511 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin
NCT00775736 ·Status: COMPLETED